The multi-target inhibitor introduced by Zai Lab over US$350 million received clinical approval for the first time
Zai Lab's Omacycline is approved and Hisun Pharmaceutical has the right to promote in China soon
Zai Lab CLDN 18.2 monoclonal antibody applied for clinical application in China
Google establishes AI drug company Isomorphic Labs, headed by DeepMind CEO
Express "first-in-class" myasthenia gravis therapy is approved by FDA, Zai Lab has China development rights
Zai Lab Class 1 new drug ``Omacycline tosylate'' will be approved soon
Berkeley Lab develops cell "silver staining" technology
The KRAS G12C inhibitor imported by Zai Lab exceeds RMB 300 million for clinical application
Zai Lab Qingle second-line treatment of gastrointestinal stromal tumor phase 3 clinical failure
New Discovery in Neuron︱Nobel Prize Lab!
$175 million in license in, Zai Lab's new drug gets new progress
Lab on a Chip: Artificial intestine model imitating human villi
Zai Lab has introduced over US$300 million, is it not too late to establish a KRAS inhibitor?
Zai Lab and Entasis Therapeutics announce positive key results of SUL-DUR Phase 3 clinical study ATTACK
15 products on the market in 2025, one global IND a year, Zai Lab transforms into 3.0, where will it go?
The new fully human VH antibody fragment ZL-1102 developed internally by Zai Lab for the clinical phase 1b study of psoriasis reached a proof of concept
Zai Lab/Amgen's FGFR2b targeted monoclonal antibody has been certified as a breakthrough therapy in China and the U.S.
Which is more accurate, blood HCG or urine HCG?
INT J LAB HEMATO: Peripheral granular lymphopenia and malformed leukocytosis as simple prognostic markers for COVID-19
Zai Lab's Nirapali ovarian cancer first-line maintenance treatment indication approved in Hong Kong, China